DEBORAH ANDREWS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Lineage Cell Therapeutics, Inc.

Filing Date Source Excerpt
2014-10-14 Deborah Andrews, 56, joined our Board of Directors during April 2014. Ms. Andrews has served as Vice President-Chief Accounting Officer of STAAR Surgical Company since 2013... The members of the Audit Committee are Stephen C. Farrell (Chairman), Deborah Andrews, and David Schlachet... The members of the Compensation Committee are Deborah Andrews (Chairman) and David Schlachet... The following table shows the annual cash fees paid to our Chairman of the Board, our directors other than the Chairman, and to the directors who served on the standing committees of the Board during 2013 and the fees that will be paid during 2014... Director other than Chairman $30,000... Audit Committee Member other than Chairman $10,000... Compensation Committee Chairman $15,000.
2015-06-11 Deborah Andrews, 57, joined our Board of Directors during April 2014. Ms. Andrews has served as Vice President-Chief Accounting Officer of STAAR Surgical Company since 2013, and served as STAAR Surgical's Vice President-Chief Financial Officer from 2005 to 2013, as its Global Controller from 2001 to 2005, and as its Vice President-International Finance from 1999 to 2001. Ms. Andrews previously worked as a senior accountant for a major public accounting firm. Ms. Andrews holds a B.S. degree in Accounting from California State University at San Bernardino. Ms. Andrews brings to our Board significant experience in finance, financial reporting, accounting and auditing, and in management as a senior financial and accounting executive of a public medical device company during a period of significant growth. The members of the Audit Committee are Stephen C. Farrell (Chairman), Deborah Andrews, and David Schlachet. The members of the Compensation Committee are Deborah Andrews (Chairwoman), David Schlachet, and Stephen L. Cartt. The following table summarizes certain information concerning the compensation paid during the past fiscal year to each of the persons who served as directors during the year ended December 31, 2014 and who were not our employees on the date the compensation was earned. Deborah Andrews received $47,125 in fees and $45,564 in option awards for a total of $92,689.
2016-04-29 Deborah Andrews, 58, joined our Board of Directors during April 2014. Ms. Andrews has served as Vice President-Chief Accounting Officer of STAAR Surgical Company since 2013... The members of the Audit Committee are Stephen C. Farrell (Chairman), Deborah Andrews, and David Schlachet... The members of the Compensation Committee are Deborah Andrews (Chairwoman), Stephen C. Farrell and David Schlachet... DIRECTOR COMPENSATION table shows Deborah Andrews total compensation of $106,427.
2017-05-01 Deborah Andrews, 59, joined our Board of Directors during April 2014. Ms. Andrews was appointed interim Chief Financial Officer of STAAR Surgical Company during April 2017... The members of the Audit Committee are Deborah Andrews (Chairwoman), Stephen C. Farrell, Michael H. Mulroy, and David Schlachet... The members of the Compensation Committee are Deborah Andrews, Stephen C. Farrell (Chairman), and David Schlachet... DIRECTOR COMPENSATION table shows Deborah Andrews total compensation of $99,073.
2018-03-29 Deborah Andrews, 60, joined our Board of Directors during April 2014. Ms. Andrews has served as Chief Financial Officer of STAAR Surgical Company since 2017 after serving as Vice President, Chief Accounting Officer since 2013. ... The members of the Audit Committee are Deborah Andrews (Chairwoman), Angus C. Russell, and David Schlachet. ... The members of the Compensation Committee are Deborah Andrews, Stephen C. Farrell (Chairman), and David Schlachet. ... DIRECTOR COMPENSATION table shows Deborah Andrews total compensation of $108,051.
2019-06-14 Deborah Andrews. Ms. Andrews has served as Chief Financial Officer of STAAR Surgical Company since September 2017 ... Ms. Andrews brings to our Board significant experience in finance, financial reporting, accounting and auditing, and in management as a senior financial and accounting executive of a public medical device company during a period of significant growth. ... Committees: Audit (Chair), Compensation ... 2018 Director Compensation ... Deborah Andrews $67,500 Fees Earned or Paid in Cash, $33,045 Option Award, Total $100,545.
2020-08-07 Deborah Andrews. Ms. Andrews served as Chief Financial Officer of STAAR Surgical Company ... Ms. Andrews brings to our Board significant experience in finance, financial reporting, accounting, and auditing, and in management as a senior financial and accounting executive of a public medical device company during a period of significant growth. ... The members of our Audit Committee are Deborah Andrews (Chair), Don M. Bailey, and Angus C. Russell. ... Deborah Andrews $67,500 Fees Earned or Paid in Cash, $23,261 Option Award, $90,761 Total.
2021-08-03 Deborah Andrews. Ms. Andrews served as Chief Financial Officer of STAAR Surgical Company (STAA), a leader in the development, manufacture, and marketing of minimally invasive ophthalmic products employing proprietary technologies, from September 2017 until June 30, 2020 after serving as Vice President, Chief Accounting Officer since 2013. ... Ms. Andrews brings to our Board significant experience in finance, financial reporting, accounting, information systems and security, and auditing, and in management as a senior financial and accounting executive of a public medical device company during a period of significant growth.
2022-04-29 Deborah Andrews. Ms. Andrews served as Chief Financial Officer of STAAR Surgical Company (STAA), a leader in the development, manufacture, and marketing of minimally invasive ophthalmic products employing proprietary technologies, from September 2017 until June 2020, after serving as Vice President, Chief Accounting Officer since 2013. ... Ms. Andrews brings to our Board significant experience in finance, financial reporting, accounting, information systems and security, and auditing, and in management as a senior financial and accounting executive of a public medical device company during a period of significant growth. ... The following table summarizes certain information concerning the compensation during our fiscal year ended December 31, 2021 to each person who served as a non-employee director during the year and who was not our employee on the date the compensation was earned. ... Deborah Andrews $73,500 Fees Earned or Paid in Cash, $89,555 Option Award, $163,055 Total.
2023-07-27 Deborah Andrews. Ms. Andrews served as Chief Financial Officer of STAAR Surgical Company (STAA), ... Ms. Andrews brings to our Board significant experience in finance, financial reporting, accounting, information systems and security, and auditing, and in management as a senior financial and accounting executive of a public medical device company during a period of significant growth. ... The table below shows the average annual cash fees for 2022 and the current cash fees, which became effective as of April 1, 2023. ... The following table summarizes certain information concerning the compensation during our fiscal year ended December 31, 2022 to each person who served as a non-employee director during the year and who was not our employee on the date the compensation was earned. ... Deborah Andrews $75,500 Fees Earned or Paid in Cash, $78,500 Option Award, $154,000 Total.
2024-04-29 Deborah Andrews. Ms. Andrews served as Chief Financial Officer of STAAR Surgical Company ... Our Board has determined that Ms. Andrews, Dr. Amin, Mr. Bailey, Mr. Bradsher, Dr. Jayasuriya, Mr. Mulroy, and Mr. Russell qualify as “independent” directors ... The table below sets forth the composition of the committees of our Board as of April 25, 2024: ... Deborah Andrews: Audit Committee Chair, Compensation Committee Member ... 2023 Non-Employee Director Compensation Table: Deborah Andrews total $148,000.
2024-12-09 The Audit Committee of our Board, which is comprised solely of independent directors Ms. Andrews, Messrs. Bailey and Mulroy, and Angus C. Russell.

Data sourced from SEC filings. Last updated: 2025-12-06